CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cadrenal Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.06−0.03 (-2.75%)
Close on Oct 19, 2026
- Market cap
- $3.09M
- P/E (TTM)
- –
- Dividend yield
- 1556.60%
SEC filings
40 of Cadrenal Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 7, 2026 | Oct 7, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Aug 31, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 24, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2026 | Jul 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2026 | Jul 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Apr 1, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Dec 23, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 16, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Dec 1, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 24, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 12, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 24, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 18, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2025 | Apr 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |